Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review
A Prakash, S Kaur, C Kaur, PK Prabha… - Indian journal of …, 2021 - journals.lww.com
OBJECTIVE: Present systematic review aimed to analyze the effect of inhaled nitric oxide
(iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC) …
(iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC) …
Unraveling the impact of nitric oxide, almitrine, and their combination in COVID-19 (at the edge of sepsis) patients: a systematic review
Y Wang, Q Yu, Y Tian, S Ren, L Liu, C Wei… - Frontiers in …, 2024 - frontiersin.org
Introduction: During the coronavirus disease 2019 (COVID-19) pandemic, a large number of
critically ill and severe COVID-19 patients meet the diagnostic criteria for sepsis and even …
critically ill and severe COVID-19 patients meet the diagnostic criteria for sepsis and even …
Utility of NO and H2S donating platforms in managing COVID-19: Rationale and promise
PP Oza, K Kashfi - Nitric Oxide, 2022 - Elsevier
Viral infections are a continuing global burden on the human population, underscored by the
ramifications of the COVID-19 pandemic. Current treatment options and supportive therapies …
ramifications of the COVID-19 pandemic. Current treatment options and supportive therapies …
HASH (0x55d844d4e9b0)
C Wild, S Wolf, G Goetz, M Walter, J McEntee… - 2020 - eprints.aihta.at
(Re-) Konvaleszenzplasma ist Plasma, das von Patient* innen gewonnen wird, die sich von
einer covid19 Erkrankung bereits erholt haben, und kann an Patient* innen abgegeben …
einer covid19 Erkrankung bereits erholt haben, und kann an Patient* innen abgegeben …
[PDF][PDF] Should inhaled nitric oxide be used in patients with COVID-19?
MK Zamora, VL Espino, CG Manalo, LF Dans - psmid.org
One open-label randomized controlled trial showed that the administration of inhaled nitric
oxide as an adjunct to standard-of-care among hospitalized patients with moderate COVID …
oxide as an adjunct to standard-of-care among hospitalized patients with moderate COVID …